In vitro studies of the efficiency of two-photon activation of photodynamic therapy agents

Mamta Khurana; Aliaksandr Karotki; Hazel Collins; Harry L. Anderson; Brian C. Wilson

doi:10.1117/12.706554

8 September 2006 In vitro studies of the efficiency of two-photon activation of photodynamic therapy agents

Mamta Khurana, Aliaksandr Karotki, Hazel Collins, Harry L. Anderson, Brian C. Wilson

Proceedings Volume 6343, Photonics North 2006; 634306 (2006) https://doi.org/10.1117/12.706554
Event: Photonics North 2006, 2006, Quebec City, Canada

Abstract

Age related macular degeneration (AMD) is a major cause of severe vision loss in the older population, due to ingrowth of new leaky blood vessels (neovasculature) from the choriocapillaris, which results in destruction of photoreceptors in the fovea and loss of central vision. "Standard" one-photon (1-γ) photodynamic therapy (PDT) using Visudyne^(R) is an approved method of AMD treatment but has the potential to damage healthy tissues lying above and below the neovasculature due to photosensitizer accumulation and its wide-beam 1-γ excitation. Highly-targeted two-photon (2-γ) excitation may avoid this, since, due to its non-linear intensity dependence, the probability of 2-γ excitation is greatest in the focal plane, which intrinsically avoids out-of-focus damage to healthy tissues. The aim of the present study is to evaluate the 2-γ efficiency of Visudyne and to compare it to the archetypal photosensitizer Photofrin^(R). Since neovascular endothelium is targeted in AMD, an endothelial cell line (YPEN-1) was selected as the in vitro model. 2-γ PDT was delivered using tightly focused ~300 fs laser pulses from a Ti:sapphire laser operating at 850 nm with 90 MHz pulse repetition rate. An assay was developed for quantification of the cellular damage using the permeability stain Hoechst 33258 and the viability stain SYTOX. Visudyne (LD₅₀= dose to kill 50% of cells: 500 J/cm², 10 M, 7.2 μg/ml) was about an order of magnitude more effective than Photofrin (LD50 : 7500 J/cm², ~42 μM, 25 μg/ml). We also demonstrate for the first time the quadratic dependence of the cellular response to 2-γ PDT. This in vitro work will lead to the design of optimized in vivo studies in animal models of AMD.

Citation Download Citation

Mamta Khurana, Aliaksandr Karotki, Hazel Collins, Harry L. Anderson, and Brian C. Wilson "In vitro studies of the efficiency of two-photon activation of photodynamic therapy agents", Proc. SPIE 6343, Photonics North 2006, 634306 (8 September 2006); https://doi.org/10.1117/12.706554

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available